JP2018533589A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018533589A5 JP2018533589A5 JP2018522753A JP2018522753A JP2018533589A5 JP 2018533589 A5 JP2018533589 A5 JP 2018533589A5 JP 2018522753 A JP2018522753 A JP 2018522753A JP 2018522753 A JP2018522753 A JP 2018522753A JP 2018533589 A5 JP2018533589 A5 JP 2018533589A5
- Authority
- JP
- Japan
- Prior art keywords
- plasminogen
- subject
- drug
- days
- deficient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562250235P | 2015-11-03 | 2015-11-03 | |
| US62/250,235 | 2015-11-03 | ||
| PCT/IB2016/001599 WO2017077380A1 (en) | 2015-11-03 | 2016-11-03 | Plasminogen replacement therapy for plasminogen-deficiency |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018533589A JP2018533589A (ja) | 2018-11-15 |
| JP2018533589A5 true JP2018533589A5 (https=) | 2019-12-12 |
| JP6878423B2 JP6878423B2 (ja) | 2021-05-26 |
Family
ID=58661917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018522753A Active JP6878423B2 (ja) | 2015-11-03 | 2016-11-03 | プラスミノーゲン欠損症のためのプラスミノーゲン補充療法 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US11291711B2 (https=) |
| EP (1) | EP3370760B1 (https=) |
| JP (1) | JP6878423B2 (https=) |
| KR (1) | KR102821400B1 (https=) |
| CN (1) | CN108289935A (https=) |
| AU (1) | AU2016347863B2 (https=) |
| BR (1) | BR112018008965A8 (https=) |
| CA (1) | CA3002915C (https=) |
| DK (1) | DK3370760T3 (https=) |
| ES (1) | ES3055824T3 (https=) |
| FI (1) | FI3370760T3 (https=) |
| IL (1) | IL258913B (https=) |
| LT (1) | LT3370760T (https=) |
| MX (1) | MX2018005588A (https=) |
| MY (1) | MY199581A (https=) |
| PL (1) | PL3370760T3 (https=) |
| PT (1) | PT3370760T (https=) |
| RS (1) | RS67519B1 (https=) |
| RU (1) | RU2736831C2 (https=) |
| SI (1) | SI3370760T1 (https=) |
| SM (1) | SMT202500451T1 (https=) |
| TW (1) | TWI801331B (https=) |
| WO (1) | WO2017077380A1 (https=) |
| ZA (1) | ZA201802820B (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201722464A (zh) * | 2015-11-10 | 2017-07-01 | 波麥堤克生化科學有限公司 | 用於傷口癒合之纖維蛋白溶酶原給藥方案 |
| CA3008185C (en) * | 2015-12-18 | 2024-01-16 | Talengen International Limited | Method for prevention or treatment of acute and chronic thrombosis |
| WO2017101867A1 (zh) | 2015-12-18 | 2017-06-22 | 深圳瑞健生命科学研究院有限公司 | 一种预防或治疗糖尿病性神经损伤及其相关病症的方法 |
| TWI624268B (zh) * | 2015-12-18 | 2018-05-21 | Talengen Institute Of Life Sciences Co Ltd | 纖溶酶原在製備藥劑上的用途及包括纖溶酶原之藥劑 |
| TWI725092B (zh) | 2015-12-18 | 2021-04-21 | 大陸商深圳瑞健生命科學硏究院有限公司 | 纖溶酶原在製備預防或治療糖尿病腎病或其相關病症之藥劑上的用途 |
| WO2017161354A1 (en) * | 2016-03-17 | 2017-09-21 | Vanderbilt University | Enhancing plasmin activity to prevent soft tissue calcification |
| WO2018107707A1 (zh) | 2016-12-15 | 2018-06-21 | 深圳瑞健生命科学研究院有限公司 | 一种改善心脏病变的方法 |
| JP7175270B2 (ja) * | 2016-12-15 | 2022-11-18 | タレンゲン インターナショナル リミテッド | グルカゴン、インスリンを正常なバランスに戻らせる方法 |
| US11207387B2 (en) | 2016-12-15 | 2021-12-28 | Talengen International Limited | Method and drug for preventing and treating obesity |
| US11154595B2 (en) * | 2016-12-15 | 2021-10-26 | Talengen International Limited | Method for preventing and treating pulmonary fibrosis |
| WO2018107688A1 (zh) * | 2016-12-15 | 2018-06-21 | 深圳瑞健生命科学研究院有限公司 | 一种预防和治疗脂肪肝的方法 |
| CA3067890A1 (en) * | 2017-06-19 | 2018-12-27 | Talengen International Limited | Method for regulating and controling glp-1/glp-1r and drug |
| CN109125715A (zh) * | 2017-06-19 | 2019-01-04 | 深圳瑞健生命科学研究院有限公司 | 一种调控glp-1/glp-1r的方法和药物 |
| TWI868051B (zh) * | 2017-06-23 | 2025-01-01 | 美商波麥堤克生物治療股份有限公司 | 與pai-1過表現相關之病狀的纖維蛋白溶酶原治療 |
| CN113597313A (zh) | 2019-01-24 | 2021-11-02 | 先觉药业咨询公司 | 用于治疗和预防微血栓形成的纤溶酶原 |
| EP3812772B1 (en) * | 2019-10-24 | 2025-02-19 | Hôpitaux Universitaires de Strasbourg (HUS) | Method for diagnosing fibrinolytic insufficiency related to neutrophil extracellular traps |
| US12497607B2 (en) | 2020-04-23 | 2025-12-16 | Previpharma Consulting Gmbh | Plasminogen for use in treating and preventing lung dysfunction |
| CN114354929A (zh) * | 2022-01-07 | 2022-04-15 | 南京鼓楼医院 | 一种用于监测人体纤溶状态的试剂盒及应用 |
| WO2025049724A1 (en) * | 2023-08-29 | 2025-03-06 | Board Of Regents Of The University Of Nebraska | Compositions and methods for treating pleural space infections and hemothorax |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2254316B1 (https=) | 1973-12-18 | 1977-04-22 | Choay Sa | |
| JP2764264B2 (ja) * | 1987-10-01 | 1998-06-11 | 株式会社ミドリ十字 | 線溶活性増強剤 |
| AT402367B (de) * | 1990-10-11 | 1997-04-25 | Immuno Ag | Pharmazeutische zubereitung auf basis von lys-plasminogen |
| AU4661493A (en) * | 1992-07-01 | 1994-01-31 | Beth Israel Hospital Boston | Enhancement of thrombolytic therapy with deglycosylated plasminogen |
| EP0682700A4 (en) * | 1993-02-05 | 1997-05-28 | Vascular Lab | USE OF UROKINASE-LIKE PLASMINOGEN ACTIVATORS IN THE INTERIOR OF PLATES FOR THE LONG-TERM INHIBITION OF THROMBOSE. |
| US20030224516A1 (en) * | 2002-06-03 | 2003-12-04 | Isis Pharmaceuticals Inc. | Antisense modulation of prox-1 expression |
| US7067492B2 (en) * | 2001-09-06 | 2006-06-27 | Omnio Ab | Method of promoting healing of a tympanic membrane perforation |
| US20050271636A1 (en) * | 2002-08-09 | 2005-12-08 | St. Jude Children's Research Hospital, Inc. | Diagnostic and therapeutic uses for prox 1 |
| GB0509438D0 (en) * | 2005-05-09 | 2005-06-15 | Prometic Biosciences Ltd | Affinity adsorbets for fibrinogen |
| AU2007290881B2 (en) * | 2006-08-28 | 2013-03-07 | Omnio Healer Ab | Candidates against infection |
| US20100028321A1 (en) * | 2006-08-28 | 2010-02-04 | Omnio Healer Ab | Drug target for preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
| WO2011004011A1 (en) * | 2009-07-10 | 2011-01-13 | Thrombogenics Nv | Variants of plasminogen and plasmin |
| CN103221070B (zh) * | 2010-08-30 | 2019-07-12 | 哈佛大学校长及研究员协会 | 用于狭窄病变和溶解血栓疗法的切变控制释放 |
| PY1577621A (es) * | 2014-12-19 | 2017-10-02 | Prometic Biotherapeutics Inc | Composicion farmaceutica que comprende plasminogeno y uso para el mismo |
| WO2017101870A1 (zh) * | 2015-12-18 | 2017-06-22 | 深圳瑞健生命科学研究院有限公司 | 一种预防或治疗糖尿病性视网膜病变的方法 |
-
2016
- 2016-11-02 TW TW105135535A patent/TWI801331B/zh active
- 2016-11-03 ES ES16861682T patent/ES3055824T3/es active Active
- 2016-11-03 MY MYPI2018000585A patent/MY199581A/en unknown
- 2016-11-03 AU AU2016347863A patent/AU2016347863B2/en active Active
- 2016-11-03 JP JP2018522753A patent/JP6878423B2/ja active Active
- 2016-11-03 PL PL16861682.9T patent/PL3370760T3/pl unknown
- 2016-11-03 WO PCT/IB2016/001599 patent/WO2017077380A1/en not_active Ceased
- 2016-11-03 CN CN201680067482.XA patent/CN108289935A/zh active Pending
- 2016-11-03 RS RS20251224A patent/RS67519B1/sr unknown
- 2016-11-03 SM SM20250451T patent/SMT202500451T1/it unknown
- 2016-11-03 US US15/771,454 patent/US11291711B2/en active Active
- 2016-11-03 FI FIEP16861682.9T patent/FI3370760T3/fi active
- 2016-11-03 BR BR112018008965A patent/BR112018008965A8/pt not_active Application Discontinuation
- 2016-11-03 RU RU2018120182A patent/RU2736831C2/ru active
- 2016-11-03 KR KR1020187015657A patent/KR102821400B1/ko active Active
- 2016-11-03 EP EP16861682.9A patent/EP3370760B1/en active Active
- 2016-11-03 LT LTEPPCT/IB2016/001599T patent/LT3370760T/lt unknown
- 2016-11-03 DK DK16861682.9T patent/DK3370760T3/da active
- 2016-11-03 CA CA3002915A patent/CA3002915C/en active Active
- 2016-11-03 PT PT168616829T patent/PT3370760T/pt unknown
- 2016-11-03 SI SI201631933T patent/SI3370760T1/sl unknown
- 2016-11-03 MX MX2018005588A patent/MX2018005588A/es unknown
-
2018
- 2018-04-24 IL IL258913A patent/IL258913B/en unknown
- 2018-04-26 ZA ZA2018/02820A patent/ZA201802820B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018533589A5 (https=) | ||
| RU2018120182A (ru) | Плазминоген-заместительная терапия при дефиците плазминогена | |
| US11446266B2 (en) | Combination composition | |
| Kumar et al. | The syndrome of irreversible acidosis after prolonged propofol infusion | |
| ES2971959T3 (es) | Terlipresina para el tratamiento de la ascitis debida a cirrosis hepática administrada como una infusión continua | |
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2013541583A5 (https=) | ||
| AU2011274652B2 (en) | A combination composition comprising ibuprofen and paracetamol | |
| EP3393517B1 (en) | Acetylsalicylic acid for use in the treatment of moderate to severe influenza | |
| Fabi et al. | Are nasal decongestants safer than rhinitis? A case of oxymetazoline-induced syncope | |
| JP2020531568A5 (https=) | ||
| JP2016510040A5 (https=) | ||
| Kurachek et al. | Inadvertent intravenous administration of racemic epinephrine | |
| EP3906934B1 (en) | Application of dalargin for the prevention of viral respiratory infections and prevention of the development of complications during viral respiratory infections | |
| Walsh et al. | A pediatric case study of treprostinil overdose | |
| Brønstad et al. | Fatal propofol infusion syndrome in a young man with status epilepticus. | |
| Zhou et al. | anesthesia care by | |
| Graff et al. | Chloroquine Ingestion to Prevent SARS-CoV-2 Infection: A Report of Two Cases | |
| Aranda et al. | Biodistribution Of [f-18] Fdg-Labeled Adult Bone Marrow-Derived Mesenchymal Stromal Cells With Pet/ct Scan In An Ards Sheep Model | |
| Nagaraj | NEUROLEPTIC MALIGNANT SYNDROME IN A CHILD WITH ORGANOPHOSPHORUS POISONING | |
| Pavcnik-Arnol et al. | SEDATION WITH SEVOFLURANE DELIVERED BY THE ANESTHETIC CONSERVING DEVICE ANACONDA® IN THE PEDIATRIC INTENSIVE CARE UNIT | |
| Yamamoto et al. | Heart Rate Response to Intravenous Landiolol during Propofol Anesthesia | |
| Nagaraj | INTERMITTENT BOLUS REGIMEN OF PROPOFOL IN CHILDREN REQUIRING SEDATION FOR AMBULATORY MAGNETIC RESONANCE IMAGING (MRI) | |
| Haitsma et al. | Surfactant Therapy | |
| Chen et al. | Wolff-Parkinson-White syndrome in an adolescent with depression |